Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

New collaborative research from the Mommersteeg Group and MRC WIMM researchers shows that a protein called Runx1 plays a significant role in the formation of the cardiac scar that forms after the heart is injured, a scar that is known to inhibit heart regeneration. In the zebrafish, a freshwater fish known to be able to fully regenerate its heart after damage, they show that the absence of Runx1 results in enhanced regeneration. This indicates a potential new therapeutic target for heart repair.

One of the major obstacles in heart regeneration is the formation of a fibrotic scar. This scar is thought to result from the deposition of collagen and fibrin by epicardial myofibroblasts after a heart attack. Preventing scarring therefore has significant therapeutic potential.

Runx1Paper20202.jpg

Associate Professor Mathilda Mommersteeg and her team, in collaboration with Jana Koth and Roger Patient from the MRC Weatherall Institute of Molecular Medicine (Radcliffe Department of Medicine), are investigating the role of transcription factor Runx1 during zebrafish heart regeneration.

Runx1 is a transcription factor that plays a key role in determining the proliferative and differential state of multiple cell-types, during both development and adulthood. The Mommersteeg Group first identified Runx1 through their research into the role of a gene called lrrc10 in the Mexican cavefish, a fish that, like the zebrafish, demonstrates an ability to repair its heart after damage .

Following this initial identification, the team and their collaborators looked into the gene in more detail. Using fluorescent transgenic reporters and single-cell sequencing, they have shown that runx1 becomes widely expressed in the heart after injury, specifically in populations of endocardial cells and thrombocytes. These populations express genes associated with scarring such as fibrin and collagen and smooth muscle genes that suggest an identity similar to myofibroblasts; the cells implicated in directly forming the cardiac scar after injury.

In runx1 mutant zebrafish, however, these subsets of endocardial cells and thrombocytes are absent, and the wounds contain less collagen and fibrin, which indicates that these cells might contribute to collagen deposition instead of epicardium-derived myofibroblasts. The researchers show that runx1 mutant animals also have increased myocardial cell survival and proliferation following heart injury, and increased expression of fibrin degradation (fibrinolysis) genes through upregulation of the plasminogen receptor Annexin 2A. Conversely, wild type fish strongly upregulate serpine1 upon injury, which inhibits fibrinolysis.

This research demonstrates that Runx1 negatively regulates regenerative responses in the heart, providing a new therapeutic target for heart regeneration.

What we found so interesting was that zebrafish, that have a natural ability to regenerate their hearts after injury, are not even doing this optimally. Absence of Runx1 further speeds up regeneration in these fish. This finding can help us understand what mechanisms improve heart regeneration and, in the future, apply this to patients after a heart attack to improve heart repair. We now first need to further find out what exactly Runx1 is doing during heart regeneration, but drugs that block Runx1 are already being tested in patients with leukaemia, making it a very promising target for treatment. - Prof Mommersteeg

The full paper "Runx1 promotes scar deposition and inhibits myocardial proliferation and survival during zebrafish heart regeneration" can be read in Development.

Credit to Development for their Research Highlight outlined in this article.

The DPAG team who have contributed to this paper include William Stockdale, Helen Potts and Professor Paul Riley.

Image Legend (above right): Adult regenerating zebrafish heart recreated with cell clusters from single cell sequencing data of runx1 mutant and wild-type hearts.

 

Similar stories

Key cause of type 2 diabetes uncovered

Research led by Dr Elizabeth Haythorne and Professor Frances Ashcroft reveals high blood glucose reprograms the metabolism of pancreatic beta-cells in diabetes. They have discovered that glucose metabolites, rather than glucose itself, are key to the progression of type 2 diabetes. Glucose metabolites damage pancreatic beta-cell function, so they are unable to release enough of the hormone insulin. Reducing the rate at which glucose is metabolised, and these glucose metabolites build up, can prevent the effects of hyperglycaemia.

New study shows clinical symptoms for Alzheimer’s can be predicted in preclinical models

Establishing preclinical models of Alzheimer’s that reflect in-life clinical symptoms of each individual is a critically important goal, yet so far it has not been fully realised. A new collaborative study from the University of Oxford has demonstrated that clinical vulnerability to an abnormally abundant protein in Alzheimer’s brain is in fact reflected in individual patient induced pluripotent stem cell-derived cortical neurons.

Updating the circuit maps of the sympathetic neural network

A new review from Professor Ana Domingos’ lab and colleagues offers a fresh modern viewpoint on sympathetic neurons and their relation to immune cells and obesity.

New Pfizer grant paves the way to a better understanding of how body fat is controlled

Professor Ana Domingos has been awarded a highly competitive independent research grant from Pfizer to discover ‘the role of Sympathetic-associated Perineurial barrier Cells in obesity’.

Collaborative MRC grant paves the way to new therapeutic targets for stress and anxiety disorders

Dr Armin Lak, Associate Professor Ed Mann and Professor Zoltán Molnár have been awarded a £733K Project Grant from the Medical Research Council on “Orexinergic projections to neocortex: potential role in arousal, stress and anxiety-related disorders”.